Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner

被引:41
作者
de Guise, Chantal
Lacerte, Annie
Rafiei, Shahrzad
Reynaud, Rachel
Roy, Melanie
Brue, Thierry
Lebrun, Jean-Jacques
机构
[1] McGill Univ, Royal Victoria Hosp, Dept Med, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada
[2] Hop Enfants La Timone, Dept Endocrinol, F-13005 Marseille, France
关键词
GROWTH-FACTOR-BETA; RAT PROLACTIN PROMOTER; BREAST-CANCER CELLS; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; EXPRESSION; PROTEIN; HORMONE; TRANSCRIPTION; ACTIVATION;
D O I
10.1210/en.2006-0444
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pituitary transcription factor Pit-1 regulates hormonal production from the anterior pituitary gland. However, the mechanisms by which Pit-1 gene expression is regulated in humans are poorly understood. Activin, a member of the TGF beta superfamily, acts as a negative regulator of cell growth and prolactin gene expression in lactotrope cells. In this study, we show that activin negatively regulates the human Pit-1 gene promoter. We defined a 117-bp element within the Pit-1 promoter that is sufficient to relay these inhibitory effects. We further investigated the signaling pathways that mediate activin-induced inhibition of Pit-1 gene promoter in pituitary lactotrope cells. We found that the activin effects on Pit-1 gene regulation are Smad independent and require the p38 MAPK pathway. Specifically, blocking p38 kinase activity reverses activin-mediated inhibition of the Pit-1 gene promoter. Together, our results highlight the p38 MAPK pathway as a key regulator of activin function in pituitary lactotrope cells and further emphasizes the critical role played by activin in regulating hormonal production in the pituitary gland.
引用
收藏
页码:4351 / 4362
页数:12
相关论文
共 45 条
[1]   Expression of human erythropoietin transgenes and of the endogenous wap gene in the mammary gland of transgenic rabbits during gestation and lactation [J].
Aguirre, A ;
Castro-Palomino, N ;
de la Fuente, J ;
Castro, FO .
TRANSGENIC RESEARCH, 1998, 7 (04) :311-317
[2]   The cytogenesis and pathogenesis of pituitary adenomas [J].
Asa, SL ;
Ezzat, S .
ENDOCRINE REVIEWS, 1998, 19 (06) :798-827
[3]   Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration [J].
Bakin, AV ;
Tomlinson, AK ;
Bhowmick, NA ;
Moses, HL ;
Arteaga, CL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36803-36810
[4]   Dopamine as a prolactin (PRL) inhibitor [J].
Ben-Jonathan, N ;
Hnasko, R .
ENDOCRINE REVIEWS, 2001, 22 (06) :724-763
[5]   CABERGOLINE - AN ADVANCE IN DOPAMINERGIC THERAPY [J].
BEVAN, JS ;
DAVIS, JRE .
CLINICAL ENDOCRINOLOGY, 1994, 41 (06) :709-712
[6]   AUTOREGULATION OF PIT-1 GENE-EXPRESSION MEDIATED BY 2 CIS-ACTIVE PROMOTER ELEMENTS [J].
CHEN, RP ;
INGRAHAM, HA ;
TREACY, MN ;
ALBERT, VR ;
WILSON, L ;
ROSENFELD, MG .
NATURE, 1990, 346 (6284) :583-586
[7]   The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin [J].
Cocolakis, E ;
Lemay, S ;
Ali, S ;
Lebrun, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18430-18436
[8]   AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene [J].
Delhase, M ;
Castrillo, JL ;
delaHoya, M ;
Rajas, F ;
HooghePeters, EL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) :32349-32358
[9]   Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].
Derynck, R ;
Zhang, YE .
NATURE, 2003, 425 (6958) :577-584
[10]   Reconstitution of the protein kinase a response of the rat prolactin promoter: Differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1 [J].
Diamond, SE ;
Chiono, M ;
Gutierrez-Hartmann, A .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (02) :228-238